Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients

Abstract

The pharmacokinetic differences detected in the elderly do not require a dose adjustment per se. Nonetheless, a lower starting dose may be appropriate as elderly hypertensive patients are usually considered to be at an increased risk of first dose hypotension at the onset of treatment with an ACE inhibitor.